Zalups R K, Barfuss D W
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207, USA.
J Toxicol Environ Health. 1995 Apr;44(4):401-13. doi: 10.1080/15287399509531969.
The disposition of mercury in the blood, kidneys and liver was evaluated and compared in rats 5 min, 1 h, and 24 h after the intravenous administration of a 0.25 mumol/kg dose of inorganic mercury or a 0.25 mumol/kg dose of inorganic mercury plus a 0.5 mumol/kg dose of cysteine to determine the possible role of extracellular cysteine and complexes of cysteine and inorganic mercury in the renal uptake and transport of inorganic mercury. More inorganic mercury was present in the blood of the rats injected with inorganic mercury alone than in the blood of the rats injected simultaneously with both the inorganic mercury and cysteine during the first hour after injection. In addition, significantly more mercury was in the plasma fraction of blood in the rats injected with both inorganic mercury and cysteine than in the rats injected with inorganic mercury alone. These findings indicate that much of the mercury injected with cysteine was in some form of a complex that allowed the mercury to be cleared from the blood more readily and prevented the mercury from entering readily into the cellular components of blood. The renal concentration of mercury was significantly greater in the rats injected with both inorganic mercury and cysteine than in the rats injected with inorganic mercury alone 1 h, but not 24 h, after injection. This increased renal accumulation of mercury during the initial hour after injection was due mainly to enhanced uptake and/or retention of mercury in the renal cortex, although some of the enhanced accumulation of mercury also occurred in the outer stripe of the outer medulla during the first hour after injection. These data indicate that coadministration of a nontoxic dose of inorganic mercury with a twofold higher amount (in moles) of cysteine increases significantly the clearance of mercury from the blood and increases the accumulation of inorganic mercury in the renal cortex and outer stripe of the outer medulla during the initial 1 h after injection. In conclusion, the data in this study are consistent with the hypothesis that complexes of inorganic mercury and cysteine in the blood and/or ultrafiltrate probably play a role in the renal uptake of some of the mercury in blood after exposure to mercuric compounds.
在静脉注射0.25 μmol/kg剂量的无机汞或0.25 μmol/kg剂量的无机汞加0.5 μmol/kg剂量的半胱氨酸后5分钟、1小时和24小时,对大鼠血液、肾脏和肝脏中汞的分布进行了评估和比较,以确定细胞外半胱氨酸以及半胱氨酸与无机汞的复合物在无机汞的肾脏摄取和转运中可能发挥的作用。在注射后的第一个小时内,单独注射无机汞的大鼠血液中的无机汞含量高于同时注射无机汞和半胱氨酸的大鼠血液中的无机汞含量。此外,同时注射无机汞和半胱氨酸的大鼠血液血浆部分中的汞含量明显高于单独注射无机汞的大鼠。这些发现表明,与半胱氨酸一起注射的大部分汞以某种复合物的形式存在,这种复合物使汞更容易从血液中清除,并阻止汞轻易进入血液的细胞成分。注射后1小时,同时注射无机汞和半胱氨酸的大鼠肾脏中的汞浓度明显高于单独注射无机汞的大鼠,但24小时后并非如此。注射后最初一小时内肾脏中汞积累的增加主要是由于肾皮质中汞的摄取和/或保留增强,尽管在注射后的第一个小时内,外髓质外层条纹中也出现了一些汞积累的增加。这些数据表明,将无毒剂量的无机汞与两倍量(摩尔)的半胱氨酸共同给药,可显著增加注射后最初1小时内汞从血液中的清除率,并增加无机汞在肾皮质和外髓质外层条纹中的积累。总之,本研究中的数据与以下假设一致:血液和/或超滤液中无机汞与半胱氨酸的复合物可能在接触汞化合物后血液中部分汞的肾脏摄取中发挥作用。